Phibro Animal Health | PAHC - Selling And Administration Expenses


Phibro Animal Health reported $78.32M in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
Align Technology USD 462.67M 2.67M Jun/2026
ANI Pharmaceuticals USD 91.66M 18.01M Jun/2026
Aurora Cannabis CAD 41.4M 781K Mar/2026
Bristol-Myers Squibb USD 1.83B 209M Jun/2026
Canopy Growth CAD 31.17M 2.27M Mar/2026
Corcept Therapeutics USD 156.9M 28.85M Jun/2026
Eli Lilly USD 3.43B 496M Jun/2026
Henry Schein USD 831M 22M Jun/2026
Idexx Laboratories USD 288.09M 11.76M Jun/2026
Knight Therapeutics CAD 35.45M 4.43M Dec/2025
Merck USD 2.89B 219M Jun/2026
Nektar Therapeutics USD 11.87M 1.7M Mar/2026
Pacira USD 91.81M 7.93M Jun/2026
Phibro Animal Health USD 78.32M 10.24M Dec/2025
Prestige Brands USD 43.3M 13.02M Jun/2026
Supernus Pharmaceuticals USD 133.64M 15.41M Jun/2026
Zoetis USD 592M 4M Jun/2026